IReL is currently engaging with publishers to renew of the following transformative agreements:
- BMJ
- Emerald
- IEEE
- Microbiology Society
- Nature
- Cell Press
- OUP
- Royal Irish Academy
- Royal Society
- Sage
- Taylor & Francis
Negotiations will be in line with the IReL Statement on TAs 2023 and aim to maintain our current read access to content and the ability to publish OA in the publishers’ journals. At this time, we cannot guarantee that authors will be offered OA publishing in 2024 on the same terms as current agreements.